Market Overview

UPDATE: Citigroup Raises PT on Cynosure Following 2Q13 Results Report

Related CYNO
Delcath Systems (DCTH) Worth Watching: Stock Soars 20.1% - Tale of the Tape
AngioDynamics Q3 Earnings Flat but Beat Ests - Analyst Blog

In a report published Thursday, Citigroup analyst Matthew J. Dodds reiterated a Buy rating on Cynosure (NASDAQ: CYNO), and raised the price target from $36.00 to $41.00.

In the report, Citigroup noted, “2Q13 results were ahead of our and the Street's expectations as the impact of the late quarter close of the PMTI deal was more pronounced than expected. Underlying trends remain healthy and we continue to expect a sizable jump in EPS in 2014 when the combined SG&A is leveraged.”

Cynosure closed on Wednesday at $28.48.

Posted-In: Citigroup Matthew J. DoddsAnalyst Color Price Target Analyst Ratings

 

Most Popular

Related Articles (CYNO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free